- Home
- LWLG vs SGMO Comparison
LWLG vs SGMO Comparison
Compare LWLG & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- SGMO
- Stock Information
- Founded
- LWLG 1991
- SGMO 1995
- Country
- LWLG United States
- SGMO United States
- Employees
- LWLG N/A
- SGMO N/A
- Industry
- LWLG Containers/Packaging
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LWLG Industrials
- SGMO Health Care
- Exchange
- LWLG Nasdaq
- SGMO Nasdaq
- Market Cap
- LWLG 126.0M
- SGMO 122.8M
- IPO Year
- LWLG N/A
- SGMO 2000
- Fundamental
- Price
- LWLG $1.24
- SGMO $0.54
- Analyst Decision
- LWLG
- SGMO Buy
- Analyst Count
- LWLG 0
- SGMO 6
- Target Price
- LWLG N/A
- SGMO $4.50
- AVG Volume (30 Days)
- LWLG 1.9M
- SGMO 5.9M
- Earning Date
- LWLG 08-08-2025
- SGMO 08-05-2025
- Dividend Yield
- LWLG N/A
- SGMO N/A
- EPS Growth
- LWLG N/A
- SGMO N/A
- EPS
- LWLG N/A
- SGMO N/A
- Revenue
- LWLG $88,105.00
- SGMO $63,756,000.00
- Revenue This Year
- LWLG N/A
- SGMO N/A
- Revenue Next Year
- LWLG N/A
- SGMO N/A
- P/E Ratio
- LWLG N/A
- SGMO N/A
- Revenue Growth
- LWLG 24.23
- SGMO 239.92
- 52 Week Low
- LWLG $0.79
- SGMO $0.30
- 52 Week High
- LWLG $4.23
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- LWLG 53.06
- SGMO 52.47
- Support Level
- LWLG $1.19
- SGMO $0.51
- Resistance Level
- LWLG $1.38
- SGMO $0.61
- Average True Range (ATR)
- LWLG 0.10
- SGMO 0.04
- MACD
- LWLG -0.01
- SGMO 0.01
- Stochastic Oscillator
- LWLG 23.68
- SGMO 65.90
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.